CPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms.
about
Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studiesMechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).Recent advances in the pharmacotherapy of infantile spasms.Neonatal and Infantile Epilepsy: Acquired and Genetic Models.In Vivo Detection of CPP-115 Target Engagement in Human Brain.Inflammation in Epileptic Encephalopathies.Neuroinflammation in epileptogenesis: Insights and translational perspectives from new models of epilepsy.Stiripentol and vigabatrin current roles in the treatment of epilepsy.Preclinical Screening for Treatments for Infantile Spasms in the Multiple Hit Rat Model of Infantile Spasms: An Update.A case report on the efficacy of vigabatrin analogue (1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115) in a patient with infantile spasms.A resurging boom in new drugs for epilepsy and brain disorders.Rational Optimization of Mechanism-Based Inhibitors through Determination of the Microscopic Rate Constants of Inactivation.Early life status epilepticus and stress have distinct and sex-specific effects on learning, subsequent seizure outcomes, including anticonvulsant response to phenobarbital.Not all that glitters is gold: A guide to critical appraisal of animal drug trials in epilepsy.INTERNEURONOPATHIES AND THEIR ROLE IN EARLY LIFE EPILEPSIES AND NEURODEVELOPMENTAL DISORDERS.
P2860
Q27308052-9CF9B3E7-634C-4CFC-841F-9BB8A52A4FA2Q37717421-F181EA03-B48A-48FC-B10E-80FC45C907A8Q38185985-2C2E0E96-119E-4155-A414-0A6E8CD83F5AQ38659279-8E7E5A7A-F3B9-487E-9936-40FA1B466EBFQ38662848-8929E736-D5F2-4E62-A6CD-F704609DBD70Q38692603-CDD757B0-1B01-4E78-AC7B-217F8638865EQ38694553-D097C6E1-F33E-42E5-B588-3B89282BA2C5Q38757727-FEC7729E-D37C-4D2A-8AA7-50D8C5D8A2CFQ40219488-CF0836A9-1047-4DCA-9EF6-8A77B1967D75Q41099058-50DEB972-9057-4CDB-A824-BDAD3C20A904Q48093388-CD582D37-8CE4-4AB1-A09B-A87C86C58450Q48136170-4F9AB986-04F7-4FA3-BD9C-10B787D2C8B8Q50629114-D130A927-A236-453B-A153-794D5709A539Q51818804-9945F095-02BA-49B9-86F0-6D1E7720DA50Q52905119-6C0A37EE-7806-4B60-AB63-7459E19BA314
P2860
CPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
CPP-115, a vigabatrin analogue ...... rat model of infantile spasms.
@ast
CPP-115, a vigabatrin analogue ...... rat model of infantile spasms.
@en
type
label
CPP-115, a vigabatrin analogue ...... rat model of infantile spasms.
@ast
CPP-115, a vigabatrin analogue ...... rat model of infantile spasms.
@en
prefLabel
CPP-115, a vigabatrin analogue ...... rat model of infantile spasms.
@ast
CPP-115, a vigabatrin analogue ...... rat model of infantile spasms.
@en
P2093
P2860
P356
P1433
P1476
CPP-115, a vigabatrin analogue ...... rat model of infantile spasms
@en
P2093
Aristea S Galanopoulou
Stephen W Briggs
Wenzhu Mowrey
P2860
P304
P356
10.1111/EPI.12424
P577
2013-10-28T00:00:00Z